BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23241597)

  • 1. Missing agreement between the two IMMULITE® PSA assays.
    Fischer K; Theil G; Hoda R; Fornara P
    Clin Chem Lab Med; 2013 Apr; 51(4):e37-9. PubMed ID: 23241597
    [No Abstract]   [Full Text] [Related]  

  • 2. New developments in the standardization of total prostate-specific antigen.
    Blijenberg BG; Storm BN; Van Zelst BD; Kruger AE; Schröder FH
    Clin Biochem; 1999 Nov; 32(8):627-34. PubMed ID: 10638945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Progress in standardization of total PSA immunoassays].
    Ishibashi M
    Rinsho Byori; 2004 Jul; 52(7):618-24. PubMed ID: 15344562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Issues on standardization of immunoassays for prostate-specific antigen: a review.
    Graves HC
    Clin Invest Med; 1993 Dec; 16(6):415-24. PubMed ID: 7516830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [PSA standardization; the past progress and some problems in the future].
    Kano S
    Nihon Rinsho; 2011 Jun; 69 Suppl 5():238-49. PubMed ID: 22207979
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparability of serum prostate-specific antigen measurement between the Roche Diagnostics Elecsys 2010 and the Abbott Architect i2000.
    Gray MA; Cooke RR; Weinstein P; Nacey JN
    Ann Clin Biochem; 2004 May; 41(Pt 3):207-12. PubMed ID: 15117434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standardization of prostate-specific antigen (PSA) assays: can interchangeability of PSA measurements be improved?
    Ishibashi M
    Clin Chem; 2006 Jan; 52(1):1-2. PubMed ID: 16391325
    [No Abstract]   [Full Text] [Related]  

  • 8. [Determination of free type and complex type prostate-specific antigen (PSA): differences in immunorecognition by Delfia PSA, ACS-PSA and Eiken PA kits].
    Sumi S; Umeda H; Koga F; Yano M; Imai T; Hosoya Y; Honda M; Maeda S; Suzuki T; Yoshida K; Negishi T
    Hinyokika Kiyo; 1996 Apr; 42(4):279-84. PubMed ID: 8693960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardization of immunoassays for prostate specific antigen. A different view based on experimental observations.
    Stamey TA; Prestigiacomo AF; Chen Z
    Cancer; 1994 Sep; 74(6):1662-6. PubMed ID: 7521782
    [No Abstract]   [Full Text] [Related]  

  • 10. Standardization of assay methods reduces variability of total PSA measurements: an Irish study.
    Forde JC; Marignol L; Blake O; McDermott T; Grainger R; Crowley VE; Lynch TH
    BJU Int; 2012 Sep; 110(5):644-50. PubMed ID: 22897326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The present status of standardization in serum total PSA measurement--a result of "Survey 2000" conducted by PSA ad hoc Committee of Japanese Urological Association].
    Kano S; Ishibashi M; Itoh Y;
    Rinsho Byori; 2001 Oct; 49(10):967-73. PubMed ID: 11769473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The present status and future directions for standardization of PSA assays in PSA gray zone].
    Kurokawa K; Yamanaka H; Ishibashi M; Kano S; Arai Y
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():117-22. PubMed ID: 12599556
    [No Abstract]   [Full Text] [Related]  

  • 13. Discordant total and free prostate-specific antigen (PSA) assays: does calibration with WHO reference materials diminish the problem?
    Stephan C; Köpke T; Semjonow A; Lein M; Deger S; Schrader M; Miller K; Jung K
    Clin Chem Lab Med; 2009; 47(11):1325-31. PubMed ID: 19778292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different prostate-specific antigen assays give different results on the same blood sample: an obstacle to recommending uniform limits for prostate biopsies.
    Stephan C; Kramer J; Meyer HA; Kristiansen G; Ziemer S; Deger S; Lein M; Loening SA; Jung K
    BJU Int; 2007 Jun; 99(6):1427-31. PubMed ID: 17355366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PSA home tests: ban in France is welcome.
    Prescrire Int; 2013 Sep; 22(141):218. PubMed ID: 24171220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prostate-specific antigen and its related parameters in detecting prostate cancer].
    Kuruma H; Egawa S
    Gan To Kagaku Ryoho; 2003 Jan; 30(1):11-5. PubMed ID: 12557698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New 'calibrator' should improve prostate cancer testing.
    Oncology (Williston Park); 1995 Nov; 9(11):1222. PubMed ID: 8703692
    [No Abstract]   [Full Text] [Related]  

  • 18. [Present status of serum total PSA assay and factors responsible for the inter-kit deviations].
    Kano S
    Nihon Rinsho; 2000 Jul; 58 Suppl():112-7. PubMed ID: 11022696
    [No Abstract]   [Full Text] [Related]  

  • 19. Analytical performance of a new one-step quantitative prostate-specific antigen assay, the FREND™ PSA Plus.
    Park HI; Lee S; Kim Y; Shin DY; Lee C; Han S; Chung C; Chang JK; Seo IB
    Clin Chem Lab Med; 2014 May; 52(5):715-23. PubMed ID: 24323891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical aspects related to the interpretation of the free-to-total PSA-ratio.
    Wolff JM; Stocker G; Borchers H; Haubeck H; Greiling H; Jakse G
    Anticancer Res; 1999; 19(4A):2633-6. PubMed ID: 10470208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.